Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

Jane A. O’Halloran, Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez, Cynthia Boucher, P. Brian Smith, Reynold A. Panettieri Jr, Sabina Mendivil Tuchia de Tai, Martin Maillo, Akram Khan, Alfredo J. Mena Lora, Matthias Salathe, Gerardo Capo, Daniel Rodríguez Gonzalez, Thomas F Patterson, Christopher Palma, Horacio Ariza, Maria Patelli Lima, Anne M. Lachiewicz, John Blamoun, Esteban C. Nannini, Eduardo Sprinz, Analia Mykietiuk, Radica Alicic, Adriana M. Rauseo, Cameron R. Wolfe, Britta Witting, Daniel K. Benjamin Jr, Steven E. McNulty, Pearl Zakroysky, Susan Halabi, Sandra Butler, Jane Atkinson, Stacey J. Adam, Richard Melsheimer, Soju Chang, Lisa LaVange, Michael Proschan, Samuel A. Bozzette, William G. Powderly, ACTIV-1 IM study group members
doi: https://doi.org/10.1101/2022.09.22.22280245

Data Availability

It is expected that the partial de-identified patient dataset will be made available via the ACTT Trial Database at NIAID - Access Clinical Data @ NIAID beginning 6 months after publication of the primary results and for 5 years following article publication.

Back to top
Posted September 26, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A. O’Halloran, Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez, Cynthia Boucher, P. Brian Smith, Reynold A. Panettieri Jr, Sabina Mendivil Tuchia de Tai, Martin Maillo, Akram Khan, Alfredo J. Mena Lora, Matthias Salathe, Gerardo Capo, Daniel Rodríguez Gonzalez, Thomas F Patterson, Christopher Palma, Horacio Ariza, Maria Patelli Lima, Anne M. Lachiewicz, John Blamoun, Esteban C. Nannini, Eduardo Sprinz, Analia Mykietiuk, Radica Alicic, Adriana M. Rauseo, Cameron R. Wolfe, Britta Witting, Daniel K. Benjamin Jr, Steven E. McNulty, Pearl Zakroysky, Susan Halabi, Sandra Butler, Jane Atkinson, Stacey J. Adam, Richard Melsheimer, Soju Chang, Lisa LaVange, Michael Proschan, Samuel A. Bozzette, William G. Powderly, ACTIV-1 IM study group members
medRxiv 2022.09.22.22280245; doi: https://doi.org/10.1101/2022.09.22.22280245
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area